Sort
40,608 grants matching “prostate cancer”
Mechanisms for GH action on epithelial cells
$382,500Shlomo Melmed · Cedars-Sinai Medical Center · R01 · FY2021 · DK
INVESTIGATING THE ROLE OF AKT1 IN PROSTATE CANCER DEVELOPMENT THROUGH PHOSPHORYLATION-DEPENDENT REGULATION OF SKP2 STABILITY & ONCOGENIC FUNCTION
$382,500Beth Israel Deaconess Medical Center, Inc. · · FY2009 · Department of the Army
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$382,471Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Targeting Vulnerabilities Exposed by Cancer Treatment-Induced Lineage Plasticity
$382,471Peter S Nelson · Fred Hutchinson Cancer Center · R01 · FY2024 · CA
Role of tumor cell cluster-induced signaling in breast cancer metastasis
$382,471Kevin Jon Cheung · Fred Hutchinson Cancer Center · R37 · FY2024 · CA
Understanding the Ligand Binding by Non-Heme Fe(II)- and 2-Oxoglutarate-Dependent Histone Demethylases
$382,448Christo Zhivkov Christov · Michigan Technological University · R15 · FY2021 · GM
QUANTITATIVE IMAGING &TREATMENT WITH FOCUSED ULTRASOUND
$382,435Interscience Research, Inc. · R44 · FY2002 · CA
NOTCH signaling controls transformation to androgen independent neuroendocrine prostate cancer
$382,429David W Goodrich · Roswell Park Cancer Institute Corp · R01 · FY2024 · CA
T-PHARMACYTES FOR PROSTATE CANCER IMMUNOTHERAPY
$382,428Massachusetts Institute Of Technology · · FY2010 · Department of the Army
Neurocognitive Changes from Long-Term Androgen Deprivation Therapy in Prostate Cancer Patients
$382,415Herta Huey-An Chao · Yale University · R01 · FY2022 · CA
Core A: Pathobiology Core
$382,412Massimo F Loda · Columbia University Health Sciences · P01 · FY2024 · CA
Novel Insights in the regulation of HIF1alpha Stability
$382,399Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA
Determining the Functional Contribution of Prostate Tumor Microenvironment in Bon
$382,378Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2014 · CA
In Vivo Oncogene-Induced Tumorigenesis and Escape
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2021 · CA
Elucidating a novel molecular biomarker for castration-resistant prostate cancer
$382,375Nima Sharifi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2021 · CA
In Vivo Oncogene-Induced Tumorigenesis and Escape
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2017 · CA
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2020 · CA
In Vivo Oncogene-Induced Tumorigenesis and Escape
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2020 · CA
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2021 · CA
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence
$382,375Lewis A Chodosh · University Of Pennsylvania · R01 · FY2018 · CA
Distributed knowledge-based platform for radiotherapy plan quality control
$382,363Kevin Lawrence Moore · University Of California, San Diego · R01 · FY2018 · HS
Cross-sectional and prospective cohort data analysis of physical activity and hea
$382,343Paul T Williams · University Of Calif-Lawrenc Berkeley Lab · R01 · FY2009 · HL
THE ROLE OF C-FLIP(L) IN REGULATING APOPTOTIC PATHWAYS IN PROSTATE CANCER
$382,338The General Hospital Corporation · · FY2008 · Department of the Army
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
$382,326Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2017 · CA
PROTOCOL SPECIFIC RESEARCH SUPPORT
$382,274Jacqueline Lyandres · University Of California, San Francisco · P30 · FY2008 · CA